Newbridge Financial Services Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-15
Closed -$76 1099
2024
Q1
$76 Buy
+15
New +$76 ﹤0.01% 1147